Mankind Pharma | Photo: Website Delhi-headquartered Mankind Pharma reported a 66 per cent year-on-year (YoY) increase in profit after tax (PAT) for the first quarter (Q1) of 2023-24 (FY24), reaching Rs 494 crore. This surge was supported by an 18 per cent YoY rise in revenue from operations, amounting to Rs 2,579 crore. The… Continue reading Mankind Pharma PAT up 66% in Q1 to Rs 494 crore on revenue growth